false

Imaging the Invisible: Granzyme B and the Future of Immunotherapy Monitoring with Guest Dr. Ben Larimer

Fractals: Life Science Conversations

Episode - Fractals - Ben Larimer

 

As a scientist, innovator, and CEO of CytoSite BioPharma, Dr. Ben Larimer has reshaped how we think about imaging immune response in cancer. His work on Granzyme B PET imaging is unlocking unprecedented insights into whether—and where—immunotherapies are working inside the body. 

In this episode of Fractals, Ben joins host Colin Miller to discuss: 

  • The origins of Granzyme B imaging and what makes it a uniquely powerful imaging agent. 
  • How CytoSite’s imaging agent revealed success in preclinical models—and sparked a new clinical path forward. 
  • The balance between scientific innovation and real-world biotech execution. 
  • Why PET imaging’s future depends on AI, cost reduction, and deeper diagnostic precision. 

Tune into Fractals: Life Science Conversations wherever you get your podcasts—and contact Bracken to learn how we help imaging agents move from molecule to market.


apple-podcast-badgeListen-on-Spotify

Click here to read the transcript version of this episode.

 

New call-to-action

 

Subscribe to receive more content